Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Washington University School of Medicine
University of Nebraska
OHSU Knight Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Arizona
Case Comprehensive Cancer Center
Stanford University
Stanford University
Children's Oncology Group
Children's Oncology Group
M.D. Anderson Cancer Center